Finally, IHC with SS18-SSX fusion-specific antibody gave diffuse positive staining to the tumor cells (Fig. 3D), and fusion gene analysis using mRNA extracted from paraffin sections revealed that the tumor had SS18 (SYT)-SSX1 fusion gene (Fig. 4). This evidence concerns the gene SSX2 and neoplasm.